Augmentation of apoptosis by the combination of bleomycin with trifluoperazine in the presence of mutant p53.

Abstract excerpt

A variety of anticalmodulin drugs can increase the cytotoxicity of bleomycin, a DNA damaging cancer chemotherapeutic. The combination has been shown to produce greater than expected DNA damage compared wot what was observed with either drug alone. Promising preclinical results led to Phase I and Phase II trials of trifluoperazine and bleomycin, which revealed activity in non-Hodgkin's lymphoma. Despite the unique...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Bleomycin
• Share to Calcium